Chidozie Ugwumba - 17 Oct 2022 Form 4 Insider Report for BiomX Inc. (PHGE)

Signature
/s/ Chidozie Ugwumba
Issuer symbol
PHGE
Transactions as of
17 Oct 2022
Net transactions value
-$26,599
Form type
4
Filing time
14 Nov 2022, 17:37:29 UTC
Previous filing
14 Nov 2022
Next filing
03 Nov 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHGE Common Stock Sale $2,713 -8,098 -0.26% $0.3350 3,063,882 17 Oct 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale $5,294 -15,300 -0.5% $0.3460 3,048,582 18 Oct 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale $1,652 -4,501 -0.15% $0.3670 3,044,081 19 Oct 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale $2,482 -6,636 -0.22% $0.3740 3,037,445 20 Oct 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale $1,998 -5,400 -0.18% $0.3700 3,032,045 21 Oct 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale $2,059 -5,900 -0.19% $0.3490 3,026,145 24 Oct 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale $1,121 -3,072 -0.1% $0.3650 3,023,073 25 Oct 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale $4,325 -12,500 -0.41% $0.3460 3,010,573 26 Oct 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale $548 -1,505 -0.05% $0.3640 3,009,068 27 Oct 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale $543 -1,526 -0.05% $0.3560 3,007,542 28 Oct 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale $1,224 -3,300 -0.11% $0.3710 3,004,242 31 Oct 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale $473 -1,300 -0.04% $0.3640 3,002,942 01 Nov 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale $867 -2,416 -0.08% $0.3590 3,000,526 02 Nov 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale $732 -2,000 -0.07% $0.3660 2,998,526 03 Nov 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale $567 -1,501 -0.05% $0.3780 2,997,025 04 Nov 2022 By SymBiosis, LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Chidozie Ugwumba is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The shares are directly held by SymBiosis, LLC.